152 related articles for article (PubMed ID: 37195918)
41. Immediate versus delayed postpartum insertion of contraceptive implant for contraception.
Sothornwit J; Werawatakul Y; Kaewrudee S; Lumbiganon P; Laopaiboon M
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011913. PubMed ID: 28432791
[TBL] [Abstract][Full Text] [Related]
42. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
[TBL] [Abstract][Full Text] [Related]
43. Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe.
Minnis AM; Etima J; Musara P; Browne EN; Mutero P; Kemigisha D; Mgodi NM; Nakabiito C; Shapley-Quinn MK; Stoner MCD; Hartmann M; Macagna N; Piper J; van der Straten A
AIDS Behav; 2022 Dec; 26(12):3848-3861. PubMed ID: 35674885
[TBL] [Abstract][Full Text] [Related]
44. Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa.
Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Kilbourne-Brook M; Mvundura M; Delany-Moretlwe S; Terris-Prestholt F
Med Decis Making; 2018 Jan; 38(1):120-133. PubMed ID: 28863752
[TBL] [Abstract][Full Text] [Related]
45. Unintended pregnancy and subsequent postpartum long-acting reversible contraceptive use in Zimbabwe.
Nance N; Ralph L; Padian N; Cowan F; Buzdugan R; Mushavi A; Mahomva A; McCoy SI
BMC Womens Health; 2018 Nov; 18(1):193. PubMed ID: 30477497
[TBL] [Abstract][Full Text] [Related]
46. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
[TBL] [Abstract][Full Text] [Related]
47. Experiences of HIV-positive postpartum women and health workers involved with community-based antiretroviral therapy adherence clubs in Cape Town, South Africa.
Trafford Z; Gomba Y; Colvin CJ; Iyun VO; Phillips TK; Brittain K; Myer L; Abrams EJ; Zerbe A
BMC Public Health; 2018 Jul; 18(1):935. PubMed ID: 30064405
[TBL] [Abstract][Full Text] [Related]
48. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
[TBL] [Abstract][Full Text] [Related]
49. Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.
Patel RC; Morroni C; Scarsi KK; Sripipatana T; Kiarie J; Cohen CR
J Int AIDS Soc; 2017 May; 20(1):21396. PubMed ID: 28530033
[TBL] [Abstract][Full Text] [Related]
50. User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa.
Sahin-Hodoglugil NN; Montgomery E; Kacanek D; Morar N; Mtetwa S; Nkala B; Philip J; Ramjee G; Cheng H; van der Straten A; The Mira Team
AIDS Care; 2011 Aug; 23(8):1026-34. PubMed ID: 21480005
[TBL] [Abstract][Full Text] [Related]
51. Association between viral suppression during the third trimester of pregnancy and unintended pregnancy among women on antiretroviral therapy: Results from the 2019 antenatal HIV Sentinel Survey, South Africa.
Woldesenbet S; Kufa T; Manda S; Ayalew K; Lombard C; Cheyip M; Puren A
PLoS One; 2022; 17(3):e0265124. PubMed ID: 35298503
[TBL] [Abstract][Full Text] [Related]
52. Contraceptive Service Uptake and Delivery Preferences in Perinatally and Horizontally Infected Female Adolescents Living with HIV: Results from a South Africa-Based Mixed-Methods Study'.
Olagbuji B; Cooper D; Mathews C; Moodley J
J Pediatr Adolesc Gynecol; 2022 Dec; 35(6):692-701. PubMed ID: 35605914
[TBL] [Abstract][Full Text] [Related]
53. End-Users' Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa.
Weinrib R; Minnis A; Agot K; Ahmed K; Owino F; Manenzhe K; Cheng H; van der Straten A
AIDS Behav; 2018 Jan; 22(1):133-145. PubMed ID: 29052018
[TBL] [Abstract][Full Text] [Related]
54. Male partner influence on family planning and contraceptive use: perspectives from community members and healthcare providers in KwaZulu-Natal, South Africa.
Kriel Y; Milford C; Cordero J; Suleman F; Beksinska M; Steyn P; Smit JA
Reprod Health; 2019 Jun; 16(1):89. PubMed ID: 31238960
[TBL] [Abstract][Full Text] [Related]
55. User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences.
Guthrie KM; Rosen RK; Vargas SE; Getz ML; Dawson L; Guillen M; Ramirez JJ; Baum MM; Vincent KL
PLoS One; 2018; 13(5):e0197269. PubMed ID: 29758049
[TBL] [Abstract][Full Text] [Related]
56. 'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda.
Alhassan Y; Twimukye A; Malaba T; Myer L; Waitt C; Lamorde M; Colbers A; Reynolds H; Khoo S; Taegtmeyer M
BMC Pregnancy Childbirth; 2022 Jul; 22(1):566. PubMed ID: 35840939
[TBL] [Abstract][Full Text] [Related]
57. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products.
Schelar E; Polis CB; Essam T; Looker KJ; Bruni L; Chrisman CJ; Manning J
Contraception; 2016 Jan; 93(1):32-43. PubMed ID: 26385588
[TBL] [Abstract][Full Text] [Related]
58. Provision of immediate postpartum contraception to women living with HIV in the Eastern Cape, South Africa; a cross-sectional analysis.
Adeniyi OV; Ajayi AI; Somefun OD; Lambert JS
Reprod Health; 2020 Dec; 17(1):194. PubMed ID: 33298097
[TBL] [Abstract][Full Text] [Related]
59. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
[TBL] [Abstract][Full Text] [Related]
60. Provision of long-acting reversible contraception in HIV-prevalent countries: results from nationally representative surveys in southern Africa.
Morse J; Chipato T; Blanchard K; Nhemachena T; Ramjee G; McCulloch C; Blum M; Saleeby E; Harper CC
BJOG; 2013 Oct; 120(11):1386-94. PubMed ID: 23721413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
